LeMaitre Vascular, Inc. Reports 3rd Consecutive Profitable Quarter (Excluding AlboGraft Charge)

Bookmark and Share

BURLINGTON, Mass., April 28, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NasdaqGM:LMAT - News), a provider of peripheral vascular devices and implants, announced Q1 2009 financial results, highlighted by continued sales growth in direct-to-hospital markets, gross margin expansion, and continued expense control. The Company posted its third consecutive quarter of adjusted non-GAAP operating profitability and increased its bottom line guidance for 2009.

MORE ON THIS TOPIC